Institut Bergonie
Bordeaux, France
Location status: Recruiting
Location contact
Sabrina CROCE
CONTACT
NCT Number: NCT06540846
Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.
Interested in participating?
Request InfoFemale
Observational
Bordeaux, France
Location status: Recruiting
Sabrina CROCE
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention since this is an observational study
Time frame: throughout the conduct of the study - an expected average of 6 months after data collection
This project aims to improve the diagnosis and prognosis of gynecologic smooth muscle tumors, including leiomyomas (LM), leiomyosarcomas (LMS), and smooth muscle tumors of uncertain malignant potential (STUMP). In detail, a workflow comprising 2 stages will be developed to automatically classify GSMT subtypes from whole-slide images and to predict progression-free survival for patients in the LMS and STUMP groups, thereby providing clinicians with a more effective tool to improve workflow quality.
Time frame: 6 months after receiving the data.
Develop a model to predict progression-free survival for STUMP group based on the features extracted from Whole Slide Images.
Contact information is provided by the study sponsor or research team.
Institut Bergonié
Other
Acronym: STUMP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07601425
Arteriovenous Malformations, Cardiovascular Abnormalities
Boston, Massachusetts, United States
View Trial DetailsNCT07728513
AI-Assisted Diagnosis, Disease
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07725510
Disease, Pathologic Processes
Guangzhou, Guangdong, China
View Trial DetailsNCT06203119
Cancer, Disease
Beijing, Beijing Municipality, China
View Trial Details